Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 Cases

Journal of Veterinary Medical Science

Volumn 68, Issue 6, 2006, Pages 581-587

  Thamm, D H ^a,b   Turek, M M ^a   Vail, D M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Canine; Mastocytoma; Prednisone; Vinblastine

Indexed keywords

ANTINEOPLASTIC AGENT; PREDNISONE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ANIMAL; ANIMAL DISEASE; ARTICLE; COHORT ANALYSIS; DOG; DOG DISEASE; FEMALE; MALE; PROGNOSIS; RETROSPECTIVE STUDY; SARCOMA; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DOG DISEASES; DOGS; FEMALE; MALE; MAST-CELL SARCOMA; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINBLASTINE;

CANIS FAMILIARIS;

EID: 33745833378     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.68.581     Document Type: Article

References (31)

1. Ayl, R. D., Couto, C. G., Hammer, A. S., Weisbrode, S., Ericson, J. G. and Mathes, L. 1992. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Vet. Pathol. 29: 386-390.
2. Bostock, D. E. 1973. The prognosis following surgical removal of mastocytomas in dogs. J. Small Anim. Pract. 14: 27-40.
3. Bostock, D. E., Crocker, D., Harris, K. and Smith, P. 1989. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. Br. J. Cancer. 59: 915-918.
4. Breslow, N. 1970. A generalized Kruskal-Wallis test for comparing k samples subject to unequal patterns of censorship. Biometrika. 57: 579-594.
5. Chaffin, K. and Thrall, D. E. 2002. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Vet. Radiol. Ultrasound. 43: 392-395.
6. Cox, D. R. 1972. Regression models and life tables. J. Roy. Statist. Soc. 34 (Ser. B): 187-220.
7. Davies, D. R., Wyatt, K. M., Jardine, J. E., Robertson, I. D. and Irwin, P. J. 2004. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J. Am. Anim. Hosp. Assoc. 40: 124-130.
8. Elmslie, R. 1997. Combination chemotherapy with and without surgery for dogs with high grade mast cell tumors with regional lymph node metastases. Vet. Cancer Soc. Newsl. 20: 6-7.
9. Emami, B. 2004. Oral cavity. pp. 997-1021. In: Principles and Practice of Radiation Oncology, 4th ed (Perez, C.A., Brady, L.W., Halperin, E.C., et al. eds), Lippincott Williams & Wilkins, Philadelphia.
10. Gerritsen, R. J., Teske, E., Kraus, J. S. and Rutteman, G. R. 1998. Multi-agent chemotherapy for mast cell tumours in the dog. Vet. Q. 20: 28-31.
11. Gieger, T. L., Theon, A. P., Werner, J. A., McEntee, M. C., Rassnick, K. M. and DeCock, H. E. 2003. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). J. Vet. Intern. Med. 17: 687-692.
12. Golden, D. L. and Langston, V. C. 1988. Uses of vincristine and vinblastine in dogs and cats. J. Am. Vet. Med. Assoc. 193: 1114-1117.
13. Hahn, K. A., King, G. K. and Carreras, J. K. 2004. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998). J. Am. Vet. Med. Assoc. 224: 79-82.
14. Hottendorf, G. H. and Neilson, S. W. 1967. Survey of 300 extirpated canine mastocytomas. Zentralbl. Veterinarmed. [A]. 14: 272-281.
15. Kaplan, E. L. and Meier, P. 1958. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53: 457-481.
16. LaDue, T., Price, G. S., Dodge, R., Page, R. L. and Thrall, D. E. 1998. Radiation therapy for incompletely resected canine mast cell tumors. Vet. Radiol. Ultrasound. 39: 57-62.
17. McCaw, D. L., Miller, M. A., Bergman, P. J., Withrow, S. J., Moore, A. S., Knapp, D. W., Fowler, D. and Johnson, J. C. 1997. Vincristine therapy for mast cell tumors in dogs. J. Vet. Intern. Med. 11: 375-378.
18. McCaw, D. L., Miller, M. A., Ogilvie, G. K., Withrow, S. J., Brewer, W. G., Klein, M. K., Bell, F. W. and Anderson, S. K. 1994. Response of canine mast cell tumors to treatment with oral prednisone. J. Vet. Intern. Med. 8: 406-408.
19. Mullins, M. N., Dernell, W. S., Withrow, S. J., Ehrhart, E. J., Thamm, D. H., Kenney, J. G. and Lana, S. E. 2006. The syndrome of multiple cutaneous canine mast cell tumors: 54 cases (1998-2004). J. Am. Vet. Med. Assoc. 228: 91-95.
20. Murphy, S., Sparkes, A. H., Smith, K. C., Blunden, A. S. and Brearley, M. J. 2004. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet. Rec. 154: 743-746.
21. Parsons, J. T., Mendenhall, W. M., Stringer, S. P., Cassisi, N. J. and Million, R. R. 1997. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity. Int. J. Radiat. Oncol. Biol. Phys. 39: 137-148.
22. Patnaik, A. K., Ehler, W. J. and MacEwen, E. G. 1984. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet. Pathol. 21: 469-474.
23. Rassnick, K. M., Moore, A. S., Williams, L. E., London, C. A., Kintzer, P. P., Engler, S. J. and Cotter, S. M. 1999. Treatment of canine mast cell tumors with CCNU (lomustine). J. Vet. Intern. Med. 13: 601-605.
24. Rowinsky, E. K. and Donehower, R. C. 1997. Antimicrotubule agents. pp. 468. In: Cancer: Principles and Practice of Oncology, 5th ed (DeVita, V.T, Hellman, S., and Rosenberg, S.A., eds), Lippincott-Raven, Philadelphia.
25. Simoes, J. P. C., Schoning, P. and Butine, M. 1994. Prognosis of canine mast cell tumors: A comparison of three methods. Vet. Pathol. 31: 637-647.
26. Thamm, D. H., Kurzman, I. D., King, I., Li, Z., Sznol, M., Dubielzig, R. R., Vail, D. M. and MacEwen, E. G. 2005. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin. Cancer Res. 11: 4827-4834.
27. Thamm, D. H., MacEwen, E. G., Phillips, B. S., Hershey, A. E., Burgess, K. M., Pettit, G. R. and Vail, D. M. 2002. Preclinical study of dolastatin-10 in dogs with spontaneous neoplasia. Cancer Chemother. Pharmacol. 49: 251-255.
28. Thamm, D. H., Mauldin, E. A. and Vail, D. M. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor: 41 cases (1992-1997). J. Vet. Intern. Med. 13: 491-497.
29. Thamm, D. H. and Vail, D. M. 2003. Mast cell tumors. pp. 261-282. In: Small Animal Clinical Oncology, 3rd ed (Withrow, S.J. and MacEwen, E.G. eds), Saunders, Philadelphia.
30. Turrel, J. M., Kitchell, B. E., Miller, L. M. and Theon, A. 1988. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J. Am. Vet. Med. Assoc. 193: 936-940.
31. Veterinary Comparative Oncology Group. 2004. Veterinary co-operative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet. Compar. Oncol. 2: 194-213.